Koers Dizal (Jiangsu) Pharmaceutical Co., Ltd.
Aandelen
688192
CNE1000055W8
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
40,78 CNY | -4,07% | -9,48% | -14,78% |
Omzet 2023 | 91,29 mln. 12,63 mln. 11,73 mln. | Omzet 2024 * | 401 mln. 55,54 mln. 51,57 mln. | Marktkapitalisatie | 16,95 mld. 2,35 mld. 2,18 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 | -1,11 mld. -153 mln. -142 mln. | Nettowinst (verlies) 2024 * | -1,01 mld. -140 mln. -130 mln. | EV/omzet 2023 | 214 x |
Nettoliquiditeiten 2023 * | - 0 0 | Nettoliquiditeiten 2024 * | - 0 0 | EV/omzet 2024 * | 42,2 x |
K/w-verhouding 2023 |
-17,6
x | K/w-verhouding 2024 * |
-16,7
x | Werknemers | 424 |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 18,48% |
1 dag | -4,07% | ||
1 week | -9,48% | ||
Lopende maand | -9,48% | ||
1 maand | -4,79% | ||
3 maanden | +30,50% | ||
6 maanden | -9,98% | ||
Lopend jaar | -14,78% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Xiao Lin Zhang
CEO | Chief Executive Officer | 60 | 27-10-17 |
Wei Wen Dong
CHM | Chairman | 38 | 01-06-18 |
Hong Bin Lu
DFI | Director of Finance/CFO | 46 | 01-07-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Simon Lü
BRD | Director/Board Member | 56 | 01-10-17 |
Xue Gong Wang
BRD | Director/Board Member | 52 | 07-09-20 |
Guan Shan Zhu
BRD | Director/Board Member | 60 | 08-09-20 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
10-05-24 | 40,78 | -4,07% | 2 833 072 |
09-05-24 | 42,51 | -1,37% | 2 725 683 |
08-05-24 | 43,1 | -4,12% | 3 110 860 |
07-05-24 | 44,95 | -2,13% | 1 869 510 |
slotkoers Shanghai S.E., 10 mei 2024
Meer koersenHerzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-14,78% | 2,45 mld. | |
+3,91% | 108 mld. | |
+10,87% | 104 mld. | |
+1,28% | 22,33 mld. | |
-13,14% | 22,19 mld. | |
-7,05% | 18,69 mld. | |
-38,36% | 17,74 mld. | |
-10,66% | 17,64 mld. | |
+3,75% | 14,05 mld. | |
+36,70% | 12,51 mld. |